Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study
Titel:
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study
Auteur:
Gupta, Vikas Kosiorek, Heidi E. Mead, Adam Klisovic, Rebecca B. Galvin, John P. Berenzon, Dmitriy Yacoub, Abdulraheem Viswabandya, Auro Mesa, Ruben A. Goldberg, Judith Price, Leah Salama, Mohamed E. Weinberg, Rona Singer Rampal, Raajit Farnoud, Noushin Dueck, Amylou C. Mascarenhas, John O. Hoffman, Ronald